Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description
- PMID: 24829216
- PMCID: PMC4834865
- DOI: 10.1093/cid/ciu359
Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description
Abstract
Background: In April 2012, the Jordan Ministry of Health investigated an outbreak of lower respiratory illnesses at a hospital in Jordan; 2 fatal cases were retrospectively confirmed by real-time reverse transcription polymerase chain reaction (rRT-PCR) to be the first detected cases of Middle East respiratory syndrome (MERS-CoV).
Methods: Epidemiologic and clinical characteristics of selected potential cases were assessed through serum blood specimens, medical record reviews, and interviews with surviving outbreak members, household contacts, and healthcare personnel. Cases of MERS-CoV infection were identified using 3 US Centers for Disease Control and Prevention serologic tests for detection of anti-MERS-CoV antibodies.
Results: Specimens and interviews were obtained from 124 subjects. Seven previously unconfirmed individuals tested positive for anti-MERS-CoV antibodies by at least 2 of 3 serologic tests, in addition to 2 fatal cases identified by rRT-PCR. The case-fatality rate among the 9 total cases was 22%. Six subjects were healthcare workers at the outbreak hospital, yielding an attack rate of 10% among potentially exposed outbreak hospital personnel. There was no evidence of MERS-CoV transmission at 2 transfer hospitals having acceptable infection control practices.
Conclusions: Novel serologic tests allowed for the detection of otherwise unrecognized cases of MERS-CoV infection among contacts in a Jordanian hospital-associated respiratory illness outbreak in April 2012, resulting in a total of 9 test-positive cases. Serologic results suggest that further spread of this outbreak to transfer hospitals did not occur. Most subjects had no major, underlying medical conditions; none were on hemodialysis. Our observed case-fatality rate was lower than has been reported from outbreaks elsewhere.
Keywords: Jordan; MERS-CoV; Middle East respiratory syndrome; novel coronavirus; seroepidemiology.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Figures
Comment in
-
Editorial commentary: still learning from the earliest known MERS outbreak, Zarqa, Jordan, April 2012.Clin Infect Dis. 2014 Nov 1;59(9):1234-6. doi: 10.1093/cid/ciu638. Epub 2014 Aug 4. Clin Infect Dis. 2014. PMID: 25091312 Free PMC article. No abstract available.
Similar articles
-
Description of a Hospital Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital in Saudi Arabia.Infect Control Hosp Epidemiol. 2016 Oct;37(10):1147-55. doi: 10.1017/ice.2016.132. Epub 2016 Jul 18. Infect Control Hosp Epidemiol. 2016. PMID: 27426423 Free PMC article.
-
Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015.BMJ Open. 2017 Jan 12;7(1):e011865. doi: 10.1136/bmjopen-2016-011865. BMJ Open. 2017. PMID: 28082362 Free PMC article.
-
2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.N Engl J Med. 2015 Feb 26;372(9):846-54. doi: 10.1056/NEJMoa1408636. N Engl J Med. 2015. PMID: 25714162 Free PMC article.
-
[Etiological, epidemiological and clinical aspects of coronavirus infection MERS-CoV].Pol Merkur Lekarski. 2015 Jan;38(223):46-50. Pol Merkur Lekarski. 2015. PMID: 25763589 Review. Polish.
-
Middle East respiratory syndrome coronavirus: implications for health care facilities.Am J Infect Control. 2014 Dec;42(12):1261-5. doi: 10.1016/j.ajic.2014.06.019. Epub 2014 Nov 25. Am J Infect Control. 2014. PMID: 25465253 Free PMC article. Review.
Cited by 156 articles
-
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.Intensive Care Med. 2020 Aug 20:1-10. doi: 10.1007/s00134-020-06211-2. Online ahead of print. Intensive Care Med. 2020. PMID: 32816098 Free PMC article.
-
Coagulopathy in COVID-19: Focus on vascular thrombotic events.J Mol Cell Cardiol. 2020 Jul 15;146:32-40. doi: 10.1016/j.yjmcc.2020.07.003. Online ahead of print. J Mol Cell Cardiol. 2020. PMID: 32681845 Free PMC article.
-
Children Infected With SARS-CoV-2 From Family Clusters.Front Pediatr. 2020 Jun 23;8:386. doi: 10.3389/fped.2020.00386. eCollection 2020. Front Pediatr. 2020. PMID: 32656172 Free PMC article.
-
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11. Am J Med Sci. 2020. PMID: 32620220 Free PMC article. Review.
-
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020. Front Immunol. 2020. PMID: 32574260 Free PMC article. Review.
References
-
- Hijawi B, Abdallat M, Sayaydeh A, et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19:S12–8. - PubMed
-
- Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–20. - PubMed
-
- World Health Organization. Global Alert and Response (GAR): novel coronavirus infection—update (Middle East respiratory syndrome coronavirus); ,. Geneva, Switzerland: WHO; Available at: http://www.who.int/csr/disease/coronavirus_infections/en . Accessed 2 May 2014.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Medical
-
Miscellaneous